Cargando…
COVID-19 convalescent plasma composition and immunological effects in severe patients
Convalescent plasma (CP) has emerged as a treatment for COVID-19. However, the composition and mechanism of action are not fully known. Therefore, we undertook a two-phase controlled study in which, first the immunological and metabolomic status of recovered and severe patients were evaluated. Secon...
Autores principales: | Acosta-Ampudia, Yeny, Monsalve, Diana M., Rojas, Manuel, Rodríguez, Yhojan, Gallo, Juan Esteban, Salazar-Uribe, Juan Carlos, Santander, María José, Cala, Mónica P., Zapata, Wildeman, Zapata, María Isabel, Manrique, Rubén, Pardo-Oviedo, Juan Mauricio, Camacho, Bernardo, Ramírez-Santana, Carolina, Anaya, Juan-Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826092/ https://www.ncbi.nlm.nih.gov/pubmed/33524876 http://dx.doi.org/10.1016/j.jaut.2021.102598 |
Ejemplares similares
-
Convalescent plasma in Covid-19: Possible mechanisms of action
por: Rojas, Manuel, et al.
Publicado: (2020) -
Mayaro: an emerging viral threat?
por: Acosta-Ampudia, Yeny, et al.
Publicado: (2018) -
Latent autoimmune thyroid disease
por: Rodríguez, Yhojan, et al.
Publicado: (2020) -
Autoimmunity is a hallmark of post-COVID syndrome
por: Rojas, Manuel, et al.
Publicado: (2022) -
Post-COVID syndrome. A case series and comprehensive review
por: Anaya, Juan-Manuel, et al.
Publicado: (2021)